Identification cholesterol metabolites altered before the onset of nonalcoholic steatohepatitis by targeted metabolomics

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)


Nonalcoholic steatohepatitis (NASH) is a disease with symptoms similar to those of alcoholic liver inflammation without alcohol intake. As an effective treatment strategy has not been established for this disease, a detailed understanding of the pathological progression mechanism is required. We focused on cholesterol metabolites, which are suspected to regulate NASH pathology, and investigated their relationship with the pathological progression in the early stages of NASH. First, the LC/MS/MS methods for bile acids and sterols were optimized and validated. Next, NASH model mice were established by feeding a choline-deficient, methionine-reduced high-fat diet, and the levels of hepatic cholesterol metabolites were measured. As a result, before the onset of NASH, desmosterol, 4β-hydroxycholesterol, campesterol, sitosterol, secondary bile acids such as taurodeoxycholic acid significantly decreased by up to 1/38 of NASH model group. Autoxidation-generated sterols significantly increased 2- to 5-fold, and various primary bile acids such as conjugated β-muricholic acids and cholic acids significantly increased 2- to 7-fold. In this study, the levels of cholesterol metabolites changed in the before the onset of NASH. These metabolic alterations involved in inflammation induction and detoxification for NASH may help the discovery of early diagnostic biomarkers in the future.

Original languageEnglish
Article number159135
JournalBiochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
Issue number5
Publication statusPublished - 2022 May


  • Bile acids
  • Cholesterol
  • Liquid chromatography electrospray ionization-tandem mass spectrometry
  • Nonalcoholic steatohepatitis
  • Oxysterols
  • Sterols

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'Identification cholesterol metabolites altered before the onset of nonalcoholic steatohepatitis by targeted metabolomics'. Together they form a unique fingerprint.

Cite this